DnB Asset Management Portfolio holdings
AUM
$24.1B
This Quarter Return
-4.53%
1 Year Return
+22.48%
3 Year Return
+110.52%
5 Year Return
+180.23%
10 Year Return
+394.81%
AUM
$21.7B
AUM Growth
+$21.7B
(-6.1%)
Cap. Flow
-$64.7M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
37.96%
Holding
778
New
46
Increased
319
Reduced
355
Closed
40
Top Buys
| 1 |
NVIDIA
NVDA
|
$276M |
| 2 |
Oracle
ORCL
|
$261M |
| 3 |
SNDK
Sandisk Corporation Common Stock
SNDK
|
$234M |
| 4 |
Booking.com
BKNG
|
$129M |
| 5 |
Lam Research
LRCX
|
$119M |
Top Sells
| 1 |
Visa
V
|
$368M |
| 2 |
Mastercard
MA
|
$249M |
| 3 |
Electronic Arts
EA
|
$238M |
| 4 |
Western Digital
WDC
|
$188M |
| 5 |
Meta Platforms (Facebook)
META
|
$139M |
Sector Composition
| 1 | Technology | 36.9% |
| 2 | Communication Services | 13.62% |
| 3 | Financials | 12.74% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Comfort Systems
FIX
$24.7B
| $380K | ﹤0.01% |
+1,179
| New | +$380K |
|
677
Real Brokerage
REAX
$1.1B
| $377K | ﹤0.01% |
+92,761
| New | +$377K |
|
678
Vaxcyte
PCVX
$4.17B
| $371K | ﹤0.01% |
9,831
+2,764
| +39% | +$104K |
|
679
NIO
NIO
$14.2B
| $354K | ﹤0.01% |
92,984
-1,100
| -1% | -$4.19K |
|
680
Kanzhun
BZ
$11.1B
| $336K | ﹤0.01% |
17,544
| – | – |
|
681
Alkermes
ALKS
$4.95B
| $328K | ﹤0.01% |
9,928
-3,248
| -25% | -$107K |
|
682
CleanSpark
CLSK
$2.65B
| $326K | ﹤0.01% |
+48,492
| New | +$326K |
|
683
Immunocore
IMCR
$1.78B
| $322K | ﹤0.01% |
10,853
+555
| +5% | +$16.5K |
|
684
Krystal Biotech
KRYS
$4.35B
| $321K | ﹤0.01% |
1,779
+242
| +16% | +$43.6K |
|
685
XPO
XPO
$14.8B
| $319K | ﹤0.01% |
+2,968
| New | +$319K |
|
686
Ambarella
AMBA
$3.36B
| $315K | ﹤0.01% |
+6,259
| New | +$315K |
|
687
Iovance Biotherapeutics
IOVA
$800M
| $305K | ﹤0.01% |
91,580
+50,802
| +125% | +$169K |
|
688
NuScale Power
SMR
$5.41B
| $293K | ﹤0.01% |
+20,659
| New | +$293K |
|
689
Amicus Therapeutics
FOLD
$2.42B
| $290K | ﹤0.01% |
35,519
+3,077
| +9% | +$25.1K |
|
690
Anavex Life Sciences
AVXL
$817M
| $285K | ﹤0.01% |
+33,261
| New | +$285K |
|
691
Iris Energy
IREN
$7.67B
| $285K | ﹤0.01% |
+46,855
| New | +$285K |
|
692
TG Therapeutics
TGTX
$5.03B
| $281K | ﹤0.01% |
+7,121
| New | +$281K |
|
693
Syndax Pharmaceuticals
SNDX
$1.39B
| $275K | ﹤0.01% |
22,378
-565
| -2% | -$6.94K |
|
694
uniQure
QURE
$954M
| $268K | ﹤0.01% |
25,320
+3,292
| +15% | +$34.9K |
|
695
Centrus Energy
LEU
$3.67B
| $268K | ﹤0.01% |
+4,312
| New | +$268K |
|
696
Butterfly Network
BFLY
$378M
| $262K | ﹤0.01% |
+114,966
| New | +$262K |
|
697
Leidos
LDOS
$22.8B
| $260K | ﹤0.01% |
+1,926
| New | +$260K |
|
698
Acadia Pharmaceuticals
ACAD
$4.34B
| $259K | ﹤0.01% |
15,611
+1,409
| +10% | +$23.4K |
|
699
Crinetics Pharmaceuticals
CRNX
$3.26B
| $249K | ﹤0.01% |
+7,431
| New | +$249K |
|
700
Immunovant
IMVT
$2.91B
| $245K | ﹤0.01% |
14,356
+3,935
| +38% | +$67.2K |
|